Avanos Medical, Inc. (AVNS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 182.2M | 180.9M | 177.8M | 175M | 167.5M | 179.6M | 170.4M | 171.7M | 166.1M | 173.3M | 171.3M | 169.4M |
| Revenue Growth % | 8.78% | 0.72% | 4.34% | 1.92% | 0.84% | 3.64% | -0.53% | 1.36% | 4.27% | -4.57% | -0.58% | -0.88% |
| Cost of Goods Sold | 88M | 94.9M | 96.7M | 82.9M | 77.7M | 80.3M | 77.5M | 76.1M | 71.3M | 78.3M | 75.8M | 71.6M |
| COGS % of Revenue | 48.3% | 52.46% | 54.39% | 47.37% | 46.39% | 44.71% | 45.48% | 44.32% | 42.93% | 45.18% | 44.25% | 42.27% |
| Gross Profit | 94.2M | 86M | 81.1M | 92.1M | 89.8M | 99.3M | 92.9M | 95.6M | 94.8M | 95M | 95.5M | 97.8M |
| Gross Margin % | 51.7% | 47.54% | 45.61% | 52.63% | 53.61% | 55.29% | 54.52% | 55.68% | 57.07% | 54.82% | 55.75% | 57.73% |
| Gross Profit Growth % | 4.9% | -13.39% | -12.7% | -3.66% | -5.27% | 4.53% | -2.72% | -2.25% | 3.72% | -7.68% | -4.69% | -3.74% |
| Operating Expenses | 5.2M | 175.3M | 68M | 84.8M | 82.5M | 86.8M | 76.2M | 79.5M | 87.4M | 72.8M | 70M | 86M |
| OpEx % of Revenue | 2.85% | 96.9% | 38.25% | 48.46% | 49.25% | 48.33% | 44.72% | 46.3% | 52.62% | 42.01% | 40.86% | 50.77% |
| Selling, General & Admin | 0 | 77.7M | 62.2M | 79M | 77.1M | 81.1M | 69M | 73.2M | 80.4M | 66M | 63.9M | 79.2M |
| SG&A % of Revenue | - | 42.95% | 34.98% | 45.14% | 46.03% | 45.16% | 40.49% | 42.63% | 48.4% | 38.08% | 37.3% | 46.75% |
| Research & Development | 5.2M | 6.1M | 5.8M | 5.8M | 5.4M | 5.7M | 7.2M | 6.3M | 7M | 6.8M | 6.1M | 6.8M |
| R&D % of Revenue | 2.85% | 3.37% | 3.26% | 3.31% | 3.22% | 3.17% | 4.23% | 3.67% | 4.21% | 3.92% | 3.56% | 4.01% |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 8.9M | -89.3M | 13.1M | 7.3M | 7.3M | 12.5M | 16.7M | 16.1M | 7.4M | 22.2M | 25.5M | 11.8M |
| Operating Margin % | 4.88% | -49.36% | 7.37% | 4.17% | 4.36% | 6.96% | 9.8% | 9.38% | 4.46% | 12.81% | 14.89% | 6.97% |
| Operating Income Growth % | 21.92% | -814.4% | -21.56% | -54.66% | -1.35% | -43.69% | -34.51% | 36.44% | 34.55% | 27.59% | 70% | 0% |
| EBITDA | 19.1M | -79.4M | 22.5M | 17.3M | 16.9M | 23.6M | 28.4M | 27.4M | 18.8M | 33.7M | 36.5M | 22.1M |
| EBITDA Margin % | 10.48% | -43.89% | 12.65% | 9.89% | 10.09% | 13.14% | 16.67% | 15.96% | 11.32% | 19.45% | 21.31% | 13.05% |
| EBITDA Growth % | 13.02% | -436.44% | -20.77% | -36.86% | -10.11% | -29.97% | -22.19% | 23.98% | 16.05% | 17.01% | 46% | 0.91% |
| D&A (Non-Cash Add-back) | 10.2M | 9.9M | 9.4M | 10M | 9.6M | 11.1M | 11.7M | 11.3M | 11.4M | 11.5M | 11M | 10.3M |
| EBIT | 0 | 3.1M | 600K | -73.9M | 11.8M | -417.7M | 12.7M | 9.3M | 4.6M | 12.2M | 2.1M | -1.6M |
| Net Interest Income | 0 | -1.3M | -1.3M | -1.4M | -600K | -2M | -2.5M | -100K | -2.5M | -2.3M | -3.8M | -3M |
| Interest Income | 200K | 600K | 500K | 600K | 1.5M | 800K | 700K | 3M | 600K | 1M | 900K | 500K |
| Interest Expense | -1.5M | 1.9M | 1.8M | 2M | 2.1M | 2.8M | 3.2M | 3.1M | 3.1M | 3.3M | 4.7M | 3.5M |
| Other Income/Expense | -1.3M | 90.5M | -14.3M | -83.2M | 2.4M | -433M | -7.2M | -9.9M | -5.9M | -13.3M | -28.1M | -16.9M |
| Pretax Income | 7.6M | 1.2M | -1.2M | -75.9M | 9.7M | -420.5M | 9.5M | 6.2M | 1.5M | 8.9M | -2.6M | -5.1M |
| Pretax Margin % | 4.17% | 0.66% | -0.67% | -43.37% | 5.79% | -234.13% | 5.58% | 3.61% | 0.9% | 5.14% | -1.52% | -3.01% |
| Income Tax | -2.5M | -2.5M | 200K | 900K | 3.1M | -23.5M | 3.6M | 1.9M | 1M | -2.1M | 6.2M | -800K |
| Effective Tax Rate % | -32.89% | -208.33% | -16.67% | -1.19% | 31.96% | 5.59% | 37.89% | 30.65% | 66.67% | -23.6% | -238.46% | 15.69% |
| Net Income | 5.1M | 3.7M | -1.4M | -76.8M | 6.6M | -397.3M | 4.3M | 1.8M | -900K | 10.5M | -3.7M | -68.1M |
| Net Margin % | 2.8% | 2.05% | -0.79% | -43.89% | 3.94% | -221.21% | 2.52% | 1.05% | -0.54% | 6.06% | -2.16% | -40.2% |
| Net Income Growth % | -22.73% | 100.93% | -132.56% | -4366.67% | 833.33% | -3883.81% | 216.22% | 102.64% | -80% | -37.87% | -123.57% | -644.8% |
| Net Income (Continuing) | 5.1M | 3.7M | -1.4M | -76.8M | 6.6M | -397M | 5.9M | 4.3M | 500K | 11M | -8.8M | -4.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | -300K | -1000K | -1000K | -1000K | -500K | 1000K | -1000K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.11 | 0.08 | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 | -0.08 | -1.46 |
| EPS Growth % | -21.43% | 100.92% | -132.72% | -4334.69% | 817.95% | -3856.52% | 216.69% | 102.68% | -82.24% | -36.11% | -123.97% | -708.33% |
| EPS (Basic) | 0.11 | 0.08 | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 | -0.08 | -1.46 |
| Diluted Shares Outstanding | 46.4M | 46.4M | 46.4M | 46.8M | 46.8M | 46M | 46.6M | 46.3M | 46.2M | 46.6M | 46.8M | 46.8M |
| Basic Shares Outstanding | 46.4M | 46.4M | 46.4M | 46.1M | 46.1M | 46M | 46M | 45.9M | 46.2M | 46.2M | 46.8M | 46.8M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |